Clinical Trial Update: Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of itraconazole in biochemically relapsed prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Carcinoma

Drugs mentioned

• Itraconazole (Itraconazole)

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Adenocarcinoma, Recurrent Prostate Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2018-10-23